AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
RIVAROXABAN in Zimbabwe
31 products registered with MCAZ — 31 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ROXELTO TABLET, COATED; ORAL | 2026/10.2/7438 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 21 May 2031 |
| ROXELTO TABLET, COATED; ORAL | 2026/10.2/7439 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 21 May 2031 |
| AXORAV 10 TABLET, COATED; ORAL | 2026/10.2/7371 | INNOVATA PHARMACEUTICALS | active | 26 Mar 2031 |
| AXORAV 20 TABLET, COATED; ORAL | 2026/10.2/7369 | INNOVATA PHARMACEUTICALS | active | 26 Mar 2031 |
| AVORAV 15 TABLET, COATED; ORAL | 2026/10.2/7370 | INNOVATA PHARMACEUTICALS | active | 26 Mar 2031 |
| RIVATAS 10 TABLET, COATED; ORAL | 2021/10.2/6192 | INTAS PHARMACEUTICAL LIMITED | active | 18 Jul 2029 |
| RIVATAS 20 TABLET, COATED; ORAL | 2021/10.2/6191 | INTAS PHARMACEUTICAL LIMITED | active | 18 Jul 2029 |
| RIROXATOR 20 TABLET, COATED; ORAL | 2022/10.2/6247 | TORRENT PHARMACEUTICALS | active | 3 Jun 2029 |
| RIROXATOR 15 TABLET, COATED; ORAL | 2022/10.2/6246 | TORRENT PHARMACEUTICALS | active | 3 Jun 2029 |
| RIROXATOR 10 TABLET, COATED; ORAL | 2022/10.2/6245 | TORRENT PHARMACEUTICALS | active | 3 Jun 2029 |
| IXAROLA 20 TABLET, COATED; ORAL | 2023/10.2/6400 | BAYER (PTY) LTD | active | 14 Apr 2028 |
| IXAROLA 15 TABLET, COATED; ORAL | 2023/10.2/6399 | BAYER (PTY) LTD | active | 14 Apr 2028 |
| IXAROLA 10 TABLET, COATED; ORAL | 2023/10.2/6398 | BAYER (PTY) LTD | active | 14 Apr 2028 |
| XAFARIV 2.5 TABLET, COATED; ORAL | 2023/10.2/6375 | MYLAN LABORATORIES LIMITED [OTL] | active | 13 Feb 2028 |
| XAFARIV 20 TABLET, COATED; ORAL | 2023/10.2/6378 | MYLAN LABORATORIES LIMITED [OTL] | active | 13 Feb 2028 |
| XAFARIV 10 TABLET, COATED; ORAL | 2023/10.2/6376 | MYLAN LABORATORIES LIMITED [OTL] | active | 13 Feb 2028 |
| XAFARIV 15 TABLET, COATED; ORAL | 2023/10.2/6377 | MYLAN LABORATORIES LIMITED [OTL] | active | 13 Feb 2028 |
| RIVAMAX 10 TABLET, COATED; ORAL | 2025/10.2/6887 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| NONE TABLET, COATED; ORAL | 2025/10.2/7069 | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | 31 Dec 2027 |
| XARELTO TABLET, COATED; ORAL | 2017/10.2/5363 | BAYER (PTY) LTD | active | 31 Dec 2027 |
| RIVA 10 TABLET, COATED; ORAL | 2021/10.2/6182 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| XARIVA-20 TABLET, COATED; ORAL | 2025/10.2/6973 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| XARIVA-15 TABLET, COATED; ORAL | 2025/10.2/6972 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| RIVA 15 TABLET, COATED; ORAL | 2021/10.2/6183 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| RIVA 20 TABLET, COATED; ORAL | 2021/10.2/6184 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| XARIVA-10 TABLET, COATED; ORAL | 2025/10.2/6971 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| XARELTO 20 TABLET, COATED; ORAL | 2017/10.2/5364 | BAYER (PTY) LTD | active | 31 Dec 2027 |
| VAROXA 10 TABLET, COATED; ORAL | 2024/10.2/6634 | MICRO LABS LIMITED | active | 31 Dec 2027 |
| XARELTO TABLET, COATED; ORAL | 2017/10.2/5362 | BAYER (PTY) LTD | active | 31 Dec 2027 |
| RIVAMAX 20 TABLET, COATED; ORAL | 2025/10.2/6888 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| VAROXA 20 TABLET, COATED; ORAL | 2024/10.2/6635 | MICRO LABS LIMITED | active | 31 Dec 2027 |
RIVAROXABAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 31 registered products containing RIVAROXABAN, of which 31 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track RIVAROXABAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.